Genetic Testing

Review Essay: Genetic Testing Is Different

Evidence Reports/Technology Assessments

Evidence Report/Technology Assessment: Number 145:
Genomic Tests for Ovarian Cancer Detection and Management
Evidence Report/Technology Assessment: Number 146:
Testing for Cytochrome P450 Polymorphisms in Adults With Non-Psychotic Depression Treated With Selective Serotonin Reuptake Inhibitors (SSRIs)
Evidence Report/Technology Assessment: Number 150:
Hereditary Nonpolyposis Colorectal Cancer: Diagnostic Strategies and Their Implications
Evidence Report/Technology Assessment: Number 160:
Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes
Evidence Report/Technology Assessment: Number 180:
Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism

Genetic Tests for Non-Cancer Diseases/Conditions: A Horizon Scan

Horizon Scan on the Use of Genetic Testing in Cancer

Top of Page

Preventive Services

Task Force Recommendations:
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility (2005)

Top of Page

Research Findings

Agency Press Releases

Date	Title
6/16/09	Value of Genetic Testing for Preventing Blood Clots Unproven, According to New AHRQ Study
9/22/08	Computer-Based Tools Will Help Make Best Use of Genetic Breast Cancer Tests

Research Activities, July 2009:
Tool helps women decide if prenatal genetic testing is the right decision for them

Research Activities, January 2009:
Researchers identify possible genetic component of penicillin allergy

Research Activities, December 2008:
Few gene variants associated with acute coronary syndrome are tied to increased deaths among such patients

Research Activities, November 2008:
New computer-based tools will help make best use of genetic breast cancer tests

Research Activities, July 2008:
AHRQ report indicates that gene-based tests need better monitoring

Research Activities, January 2008:
Researchers determine risk factors for deadly infection after open-chest surgeries in children

Research Activities, October 2006:
New evidence report finds most genomic tests to identify or treat ovarian cancer have not shown clinical value

Research Activities, June 2006:
Disadvantaged blacks differ from disadvantaged whites in beliefs about genetic testing

Research Activities, September 2005:
Task Force issues recommendation against routing testing for genetic risk of breast or ovarian cancer in the general population

Top of Page